Although the number of Medicaid prescription drug orders has decreased in recent years, Medicaid spending on such drugs has increased, largely due to high-cost brand drugs. From 2017 to 2022, net spending on Medicaid prescriptions rose by 47%. Federal measures are being introduced to mitigate high prescription costs, including the Lower Costs, More Transparency Act and initiatives to improve price transparency.
Group-IB’s Threat Intelligence and Defence Centre Equip Undergraduates with Sophisticated Cybersecurity Technologies to Boost Threat Analysis and Enhance Cyber Resilience for Campus Start-ups
Hey there from the heart of the San Francisco Bay Area! It’s an absolute pleasure to have you back again for our chat on some
